Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b

Martins, Reinaldo de Menezes; Camacho, Luiz Antonio Bastos; Marcovistz, Rugimar; Noronha, Tatiana Guimarães de; Maia, Maria de Lourdes Sousa; Santos, Eliane Matos dos; Barbosa, Glayse Glayde; Silva, Andrea Marques Vieira da; Souza, Patricia Cristina Neves Feliciano de; Lemos, Maria Cristina Ferreira; Homma, Akira.
Mem. Inst. Oswaldo Cruz ; 103(7): 711-718, Nov. 2008. ilus, tab
Artículo en Inglés | LILACS | ID: lil-498381

Documentos relacionados

  1. Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b.
  2. The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule.
  3. Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System.
  4. Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
  5. FACTORS INFLUENCING ANTI-POLYRIBOSYLRIBITOL PHOSPHATE TITRES IN YOUNG NIGERIAN CHILDREN PRIMED WITH DTWP-HEPB-HIB VACCINE.
  6. Antibody persistence to diphtheria toxoid, tetanus toxoid, <i>Bordetella pertussis</i> antigens, and <i>Haemophilus influenzae</i> type b following primary and first booster with pentavalent versus hexavalent vaccines.
  7. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study.
  8. Immunogenicity and safety of a DTaP-IPV/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan.
  9. Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal.
  10. Economic impact of switching from partially combined vaccine "Pentaxim® and hepatitis B" to fully combined vaccine "Hexaxim®" in the Malaysian National Immunization Program.